- Bellerophon Therapeutics (BLPH) +67% on positive top-line data from a recently completed acute, intra-patient, dose escalation, hemodynamics study of INOpulse for the treatment of Pulmonary Hypertension associated with Pulmonary Fibrosis.
- Stealth BioTherapeutics (MITO) +33% on "positive" elamipretide data.
- Legg Mason (LM) +23% as Franklin Templeton agrees to buy Legg Mason for $50/share.
- Wanda Sports Group (WSG) +18%.
- Franklin Resources (BEN) +13% as it agrees to buy Legg Mason for $50/share.
- GSX Techedu (GSX) +13% on Q4 results.
- Viveve Medical (VIVE) +12%.
- Front Yard Residential (RESI) +11% on being acquired in $2.3B deal.
- Virgin Galactic Holdings (SPCE) +11% ahead of conference presentation.
- Cemtrex (CETX) +11%.
- AIM ImmunoTech (AIM) +8% on the potential role of Ampligen for use against the Wuhan Coronavirus epidemic.
- Advance Auto Parts (AAP) +7% on Q4 results.
- Inovio Pharmaceuticals (INO) +7%.
- InMode (INMD) +7% on Q4 results.
- Senseonics Holdings (SENS) +7% on positive coverage decision for Eversense CGM from Cigna.
- The Kroger (KR) +6% as Berkshire Hathaway reports stake.
- Sibanye Gold (SBGL) +6%.
- Gulfport Energy (GPOR) +6%.
- Tesla (TSLA) +5% as Tesla looks at cobalt-free batteries.